Express Scripts improves patient access to digital health solutions
Press releases may be edited for formatting or style | December 12, 2019
Health IT
Primary Care
ST. LOUIS, Dec. 12, 2019 /PRNewswire/ -- As more people turn to digital programs to improve their health, Express Scripts is making it easier to connect consumers with the apps and devices that work best for them.
Today, Express Scripts announced the first formulary for digital and mobile health apps and devices – a fast-growing segment of health care that aims to help people with serious illnesses like diabetes and high blood pressure to take better control of their health, improve their quality of life and lower their total costs.
Participating health plans and employers can increase patients' access to emerging products and technologies simply and affordably, and can rest easier with the knowledge that these new tools have been reviewed by a team of experts who will ensure the products work, provide a user-friendly experience and are worth the investment. People who use a program on the Digital Health Formulary also will receive support from Express Scripts specialist pharmacists to ensure appropriate use of the technology.
"The Express Scripts Digital Health Formulary will do for the developing digital health care industry what our drug formularies have achieved for prescription medications for more than 20 years – access, choice and value for payers and patients," said Mark Bini, chief patient experience officer, Express Scripts. "We are setting the bar high for clinical effectiveness, user experience and financial value for these solutions, while also combining coverage into the pharmacy benefit and providing patients with expert support from Express Scripts specialist pharmacists."
Starting in January 2020, the Express Scripts Digital Health Formulary initially includes 15 solutions including remote monitoring services and digital therapeutics that aid in the management of eight of the country's most common chronic conditions: diabetes, prediabetes, hypertension, asthma, pulmonary disease, depression, anxiety and insomnia. The first selected solutions on the formulary include:
Livongo, which will have preferred status on the formulary, for their diabetes, diabetes prevention and hypertension family of products
Omada Health digital care programs for diabetes, diabetes prevention and hypertension
LifeScan OneTouch Reveal® Plus powered by Welldoc's BlueStar® platform for diabetes
Learn to Live and SilverCloud Health digital mental health platforms for depression, anxiety and insomnia
|
|
|
You Must Be Logged In To Post A Comment
|
